How and when to reverse anticoagulation in the bleeding EM patient.
Hosts:
Joe Offenbacher, MD
Audrey Bree Tse, MD
Once we get past plateletar aggregation, the coagulation process takes over. Inhibiting vinaman k impacts points along the intrinse, extrinsic and common pathways. Soe, you did it. Great review. And for a listeners, take a look at our show notes for pictorial of the crogulation thways.